Your browser doesn't support javascript.
loading
Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry.
Wei, Xuyong; Xie, Wentao; Yin, Weiwei; Yang, Mengfan; Khan, Abdul Rehman; Su, Renyi; Shu, Wenzhi; Pan, Binhua; Fan, Guanghan; Wang, Kun; Yang, Fan; Lu, Di; Li, Changbiao; Pan, Linhui; Cen, Beini; Xie, Haiyang; Zhuang, Li; Zheng, Shusen; Zeng, Xun; Chen, Wei; Xu, Xiao.
Afiliação
  • Wei X; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Xie W; NHFPC Key Laboratory of Combined Multi-Organ Transplantation Hangzhou 310003, China.
  • Yin W; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Yang M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou 310003, China.
  • Khan AR; NHFPC Key Laboratory of Combined Multi-Organ Transplantation Hangzhou 310003, China.
  • Su R; Key Laboratory for Biomedical Engineering of The Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University Hangzhou 310058, China.
  • Shu W; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Pan B; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou 310003, China.
  • Fan G; NHFPC Key Laboratory of Combined Multi-Organ Transplantation Hangzhou 310003, China.
  • Wang K; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Yang F; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou 310003, China.
  • Lu D; NHFPC Key Laboratory of Combined Multi-Organ Transplantation Hangzhou 310003, China.
  • Li C; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Pan L; NHFPC Key Laboratory of Combined Multi-Organ Transplantation Hangzhou 310003, China.
  • Cen B; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Xie H; NHFPC Key Laboratory of Combined Multi-Organ Transplantation Hangzhou 310003, China.
  • Zhuang L; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Zheng S; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou 310003, China.
  • Zeng X; NHFPC Key Laboratory of Combined Multi-Organ Transplantation Hangzhou 310003, China.
  • Chen W; Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou 310006, China.
  • Xu X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou 310003, China.
Am J Cancer Res ; 12(9): 4160-4176, 2022.
Article em En | MEDLINE | ID: mdl-36225628

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China